Evidence map›Paper›PMID 28829668›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Long-Term, Supplemental, One-Carbon Metabolism-Related Vitamin B Use in Relation to Lung Cancer Risk in the Vitamins and Lifestyle (VITAL) Cohort.

Theodore M Brasky, Emily White, Chi-Ling Chen

Abstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 2 pooled it
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 2 syntheses or guidelines pooled it, 137 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Vitamin BNutrients · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Theodore M BraskyTheodore M. Brasky, The Ohio State University College of Medicine, Columbus, OH; Theodore M. Brasky and Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Chi-Ling Chen, College of Public Health and College of Medicine, National Taiwan University, Taipei, Taiwan.
Emily WhiteTheodore M. Brasky, The Ohio State University College of Medicine, Columbus, OH; Theodore M. Brasky and Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Chi-Ling Chen, College of Public Health and College of Medicine, National Taiwan University, Taipei, Taiwan.
Chi-Ling ChenTheodore M. Brasky, The Ohio State University College of Medicine, Columbus, OH; Theodore M. Brasky and Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Chi-Ling Chen, College of Public Health and College of Medicine, National Taiwan University, Taipei, Taiwan.
Fred Hutch Cancer Center · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Cancer Prevention Trng-Nutrition, Exercise &GeneticsR25CA094880 · NCI · UNIVERSITY OF WASHINGTON · PI WHITE, EMILY · 2002 to 2016
$7.3M
Established Investigator Award Anti-Inflammatory Exposures in Cancer PreventionK05CA154337 · NCI · UNIVERSITY OF WASHINGTON · PI WHITE, EMILY · 2011 to 2015
$637k
NCI NIH HHS K05 CA154337NCI NIH HHS P30 CA016058NCI NIH HHS R25 CA094880
6 · The paper itself

Abstract

Purpose Inconsistent findings have been reported of a link between the use of one-carbon metabolism-related B vitamins and lung cancer risk. Because of the high prevalence of supplemental vitamin B use, any possible increased association warrants further investigation. We examined the association between long-term use of supplemental B vitamins on the one-carbon metabolism pathway and lung cancer risk in the Vitamins and Lifestyle (VITAL) cohort, which was designed specifically to look at supplement use relative to cancer risk. Methods A total of 77,118 participants of the VITAL cohort, 50 to 76 years of age, were recruited between October 2000 and December 2002 and included in this analysis. Incident, primary, invasive lung cancers (n = 808) were ascertained by prospectively linking the participants to a population-based cancer registry. The 10-year average daily dose from individual and multivitamin supplements were the exposures of primary interest. Results Use of supplemental vitamins B

Indexed as

Dietary SupplementsLife StyleAgedCohort StudiesFemaleFolic AcidHealth SurveysHumansIncidenceLung NeoplasmsMaleMiddle AgedMultivariate AnalysisProportional Hazards ModelsRisk FactorsTime FactorsFolic AcidVitamin B 12Vitamin B 6Vitamin B Complex

Identifiers

PMID28829668
PMCPMC5648175
OpenAlexW2750003831

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.